Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention

Addictive Behaviors

Volumn 36, Issue 6, 2011, Pages 615-623

  Magidson, Jessica F ^a,b   Gorka, Stephanie M ^a   MacPherson, Laura ^b   Hopko, Derek R ^c   Blanco, Carlos ^d   Lejuez, C W ^b   Daughters, Stacey B ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Behavioral activation; Depression; Reinforcement; Substance use; Treatment retention

Indexed keywords

ADULT; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; COUNSELING; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; LIFE ENHANCEMENT TREATMENT FOR SUBSTANCE USE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; SUPPORTIVE COUNSELING; TREATMENT DURATION; TREATMENT RETENTION;

ADULT; COUNSELING; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RESIDENTIAL TREATMENT; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; WASHINGTON;

EID: 79953163937     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2011.01.016     Document Type: Article

References (63)

1. Alterman A.I., McLellan A.T., Shifman R.B. Do substance abuse patients with more psychopathology receive more treatment?. The Journal of Nervous and Mental Disease 1993, 181:576-582.
2. Armento M.E., Hopko D.R. The Environmental Reward Observation Scale (EROS): Development, validity, and reliability. Behavior Therapy 2007, 38:107-119.
3. Azrin N.H., McMahon P., Donohue B., Besalel V.A., Lapinski K.J., Kogan E.S., et al. Behavior therapy of drug abuse: A controlled outcome study. Behaviour Research and Therapy 1994, 32:857-866.
4. Beck A.T., Steer R.A., Ball R., Ranieri W.F. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment 1996, 67(3):588-597.
5. Bellg A.J., Borelli B., Resnick B., Hetcht J., Minicucci D.S., Ory M., et al. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium. Health Psychology 2004, 23(5):443-451.
6. Carpenter K.M., Brooks A.C., Vosburg S.K., Nunes E.V. The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: A controlled clinical trial. Drug and Alcohol Dependence 2004, 74(2):123-134.
7. Carroll M.E. Reducing drug abuse by enriching the environment with alternative nondrug reinforcers 1996, Ablex Publishing Corporation, New York.
8. Cuijpers P., Van Straten A., Warmerdam L. Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review 2007, 27:318-326.
9. Daughters S.B., Braun A.R., Sargeant M.N., Reynolds E.K., Hopko D.R., Blanco C., et al. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The Life Enhancement Treatment for Substance Use (LETS ACT!). The Journal of Clinical Psychiatry 2008, 69(1):122-129.
10. De Leon G., Melnick D., Kressel N., Jainchill N. Circumstances, motivation, readiness, and suitability (The CMRS Scales): Predicting retention in therapeutic community treatment. The American Journal of Drug and Alcohol Abuse 1994, 20(4):495-515.
11. Ekers D., Richards D., Gilbody S. A meta-analysis of randomized trials of behavioural treatment of depression. Psychological Medicine 2007, 38:611-623.
12. First M.B., Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). Personality assessment 2004, Vol. 2. John Wiley & Son, Hoboken, NJ. M.J. Hilsenroth, D.L. Segal (Eds.).
13. Green L., Kagel J.H. Advances in behavioral economics. Substance Use and Abuse 1996, Volume 3. Ablex Publishing Corporation, New York.
14. Greenfield S.F., Weiss R.D., Muenz L.R., Vagge L.M., Kelly J.F., Bello L.R., et al. The effect of depression on return to drinking: A prospective study. Archives of General Psychiatry 1998, 55(3):259-265.
15. Grella C., Gil-Rivas V., Cooper L. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. The Journal of Behavioral Health Services & Research 2004, 31:38-49.
16. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2005, 62(10):1097-1106.
17. Hasin D., Liu X., Nunes E., McCloud S., Samet S., Endicott J. Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry 2002, 59(4):375-380.
18. Higgins S.T., Heil S.H., Lussier J.P. Clinical implications of reinforcement as a determinant of substance use disorders. Annual Review of Psychology 2004, 55:431-461.
19. Hill C.E. Helping skills: Facilitating exploration, insight, and action 2004, 63-175. American Psychological Association, Washington, DC. 2nd ed.
20. Hopko D.R., Bell J.L., Armento M.E., Hunt M.K., Lejuez C.W. Behavior therapy for depressed cancer patients in primary care. Psychotherapy: Theory, Research, Practice, Training 2005, 42:236-243.
21. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry 2006, 67:1062-1073.
22. Hubbard R.L., Craddock S.G., Anderson J. Overview of 5-year follow-up outcomes in the Drug Abuse Treatment Outcome Studies (DATOS). Journal of Substance Abuse Treatment 2003, 25:125-134.
23. Jacobson N.S., Dobson K.S., Truax P.A., Addis M.E., Koerner K., Gollan J.K., et al. A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology 1996, 64(2):295-304.
24. Jacobson J.O., Robinson P.L., Bluthenthal R.N. Racial disparities in completion rates from publicly funded alcohol treatment. Health Services Research 2007, 42:773-794.
25. Johnson M.E., Neal D.B., Brems C., Fisher D.G. Depression among out-of-treatment injecting drug users as measured by the Beck Depression Inventory-2. Assessment 2006, 13(2):168-177.
26. Kanter J.W., Mulick P.S., Busch A.M., Berlin K.S., Martell C.R. The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment 2007, 29:191-202.
27. Kanter J.W., Rusch L.C., Busch A.M., Sedivy S.K. Validation of the Behavioral Activation for Depression Scale (BADS) in a community sample with elevated depressive symptoms. Journal of Psychopathology and Behavioral Assessment 2009, 31:36-42.
28. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003, 289:3095-3105.
29. Kosten T., Oliveto A., Feingold A., Poling J., Sevarino K., McCance-Katz E., et al. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence 2003, 70(3):315-325.
30. Lasa L., Ayuso-Mateos J.L., Vazques-Barquero J.L., Diez-Manrique F.J., Dowrick C.F. The use of the Beck Depression Inventory to screen for depression in the general population: A preliminary analysis. Journal of Affective Disorders 2000, 57:261-265.
31. Lejuez C.W., Hopko D.R., Hopko S.D. A brief Behavioral Activation Treatment for Depression: treatment manual. Behavior Modification 2001, 25:255-286.
32. Lejuez C.W., Zvolensky M.J., Daughters S.B., Bornovalova M.A., Paulson A., Tull M.T., et al. Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behaviour Research and Therapy 2008, 46(7):811-818.
33. Lewinsohn P.M. A behavioral approach to depression. The Psychology of Depression: Contemporary Theory and Research 1974, Wiley, New York, NY. R.M. Friedman, M.M. Katz (Eds.).
34. Liappas J., Paparrigopoulos E., Tzavellas G., Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug and Alcohol Dependence 2002, 68:215-220.
35. Little R.J., Yau L.H.Y. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 1996, 52:1324-1333.
36. Maier W., Philipp M. Improving the assessment of severity of depressive states: A reduction of the Hamilton Depression Rating Scale. Pharmacopsychiatry 1985, 18:114-115.
37. Manne S., Rubin S., Edelson M., Rosenblum N., Bergman C., Hernandez E., et al. Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers. Journal of Consulting and Clinical Psychology 2007, 75(4):615-628.
38. Manos R.C., Kanter J.W., Busch A.M. A critical review of assessment strategies to measure the behavioral activation model of depression. Clinical Psychology Review 2010, 30:547-561.
39. Mark T.L., Coffey R.M. What drove private health insurance spending on mental health and substance abuse care, 1992-1999. Health Affairs 2003, 22:165-172.
40. Mark T.L., Coffey R.M., Vandivort-Warren R., Harwood H.J., King E.C. U.S. spending for mental health and substance abuse treatment, 1991-2001. Health Affair Web Exclusive 2005, W5-133-142.
41. Marlatt G.A., Tucker J.A., Donovan D.M., Vuchinich R.E. Help-seeking by substance abusers: The role of harm reduction and behavioral-economic approaches to facilitate treatment entry and retention. NIDA Research Monograph 1997, 165:44-84.
42. Mazzuchelli T., Kane R., Rees C. Behavioral activation treatments for depression in adults: A meta-analysis and review. Clinical Psychology: Science and Practice 2009, 16:383-411.
43. McIntyre R.S., Konarski J.Z., Mancini D.A., Fulton K.A., Parikh S.V., Grigoriadis S., et al. Measuring the severity of depression and remission in primary care: Validation of the HAMD-7 scale. Canadian Medical Association Journal 2005, 17(11):1327-1334.
44. McKay J.R., Pettinati H.M., Morrison R., Feeley M., Mulvaney F.D., Gallop R. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychology of Addictive Behaviors 2002, 16(3):225-235.
45. Melnick G. Assessing treatment readiness in special populations, final report of project activities 1999, National Institute on Drug Abuse, Rockville, MD.
46. Moneyham L., Sowell R., Seals B., Demi A. Depressive symptoms among African American women with HIV. Scholarly Inquiry for Nursing Practice 2000, 14:9-39.
47. Moos R.H., Mertens J.R., Brennan P.L. Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. Journal of Studies on Alcohol and Drugs 1994, 55:561-570.
48. Murphy J.G., Correia C.J., Barnett N.P. Behavioral economic approaches to reduce college student drinking. Addictive Behaviors 2007, 32(11):2573-2585.
49. Nezu A.M., Ronan G.F., Meadows E.A., McClure K.S. Practitioners guide to empirically based measures of depression 2000, Kluwer Academic/Plenum Publishers, New York.
50. Nunes E.V., Sullivan M.A., Levin F.R. Treat of depression in patients with opiate dependence. Biological Psychiatry 2004, 56:793-802.
51. Rachman S., Hodgson R. Synchrony and desynchrony in fear and avoidance. Behaviour Research and Therapy 1974, 12:311-318.
52. Rounsaville B.J., Kosten T.R., Kleber H.D. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Comprehensive Psychiatry 1986, 27:480-498.
53. Rounsaville B.J., Kosten T.R., Weissman M.M., Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Archives of General Psychiatry 1986, 43(8):739-745.
54. Satel S.L., Price L.H., Palumbo J.M., McDougle C.J., Krystal J.H., Gawin F., et al. Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. The American Journal of Psychiatry 1991, 148(12):1712-1716.
55. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and follow-up outcomes in DATOS. Psychology of Addictive Behaviors 1997, 11:294-307.
56. Sturmey P. Behavioral activation is an evidence-based treatment for depression. Behavior Modification 2009, 33:818-829.
57. Tate S.R., Brown S.A., Unrod M., Ramo D.E. Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders. Addictive Behaviors 2004, 29:1707-1724.
58. Thase M.E., Friedman E.S., Berman S.R., Fasiczka A.L., Lis J.A., Howland R.H., et al. Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo. Journal of Affective Disorders 2000, 57:63-71.
59. Thase M.E., Salloum I.M., Cornelius J.D. Comorbid alcoholism and depression: treatment issues. The Journal of Clinical Psychiatry 2001, 62:32-41.
60. Timko C.J. Policies and services in residential substance abuse programs: Comparisons with psychiatric programs. Journal of Substance Use 1995, 7:43-59.
61. Timko C., Lesar M., Calvi N., Moos R. Trends in acute mental health care: Comparing psychiatric and substance abuse treatment programs. The Journal of Behavioral Health Services & Research 2003, 30:145-160.
62. Torrens M., Fonseca F., Mateu G., Farré M. Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systematic review and meta-analysis. Drug and Alcohol Dependence 2005, 78:1-22.
63. Van Etten M.L., Higgins S.T., Budney A.J., Badger G.J. Comparison of the frequency and enjoyability of pleasant evens in cocaine abusers vs. non-abusers using a standardized behavioral inventory. Addiction 1998, 93(11):1669-1680.